In addition, staining for ICAM-1 in human postmortem brains, showed its age-associated reduction in the CP epithelium, in line with our previous observations25, and quantitative assessment of this effect revealed further decline in AD patients compared with aged individuals without CNS disease (Fig. 1c,d). Here, ICAM1 is linked to Alzheimer disease.